Skip to main content
. 2017 Jul 27;140(9):2460–2474. doi: 10.1093/brain/awx172

Figure 4.

Figure 4

MAOB versus other astrocyte markers. Comparison of changes (% above control) in levels of the astroglial marker proteins in putamen of patients with MSA and in substantia nigra of patients with PSP. Data for Hsp27, vimentin and GFAP were previously published (Tong et al., 2015).